title: Analyzing 54,936 Samples Supports the Association Between CD2AP rs9349407 Polymorphism and Alzheimer's Disease Susceptibility.
abstract: The CD2-associated protein (CD2AP) rs9349407 polymorphism was first identified to be significantly associated with Alzheimer's disease (AD) in European ancestry by genome-wide association studies (GWAS). However, the following studies reported no association in Chinese, Japanese, African-American, Canadian, and European populations. We think that these negative results may have been caused by either relatively small sample sizes compared with those used for the previous GWAS in European ancestry or the genetic heterogeneity of the rs9349407 polymorphism in different populations. Here, we reevaluated this association using the relatively large-scale samples from 15 previous studies (N = 54,936; 23,777 cases and 31,159 controls) by searching the PubMed, AlzGene, and Google Scholar databases. Using an additive genetic model, we did not identify a significant heterogeneity among the 15 studies. Using meta-analysis, we observed a significant association between the rs9349407 polymorphism and AD with P = 8.78E-07, odds ratio (OR) = 1.08, 95% confidence interval (CI) 1.05-1.12. To our knowledge, this is the first meta-analysis to investigate the association between rs9349407 polymorphism and AD in East Asian, American, Canadian, and European populations. Our analysis further supports previous findings that the CD2AP rs9349407 polymorphism contributes to AD susceptibility. We believe that our findings will be very useful for future genetic studies on AD.
authors.affiliation: Department of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
authors.forename: Hongyuan
authors.initials: H
authors.lastname: Chen
authors.forename: Guihua
authors.initials: G
authors.lastname: Wu
authors.forename: Yongshuai
authors.initials: Y
authors.lastname: Jiang
authors.forename: Rennan
authors.initials: R
authors.lastname: Feng
authors.forename: Mingzhi
authors.initials: M
authors.lastname: Liao
authors.forename: Liangcai
authors.initials: L
authors.lastname: Zhang
authors.forename: Guoda
authors.initials: G
authors.lastname: Ma
authors.forename: Zugen
authors.initials: Z
authors.lastname: Chen
authors.forename: Bin
authors.initials: B
authors.lastname: Zhao
authors.forename: Keshen
authors.initials: K
authors.lastname: Li
authors.forename: Chunjiang
authors.initials: C
authors.lastname: Yu
authors.forename: Guiyou
authors.initials: G
authors.lastname: Liu
mesh_terms: D048868:Adaptor Proteins, Signal Transducing / Q000235:genetics*; D000544:Alzheimer Disease / Q000235:genetics*; D003598:Cytoskeletal Proteins / Q000235:genetics*; D018740:Genetic Heterogeneity; D020022:Genetic Predisposition to Disease; D055106:Genome-Wide Association Study; D006801:Humans; D008957:Models, Genetic; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D017594:Publication Bias
chemical_list: D048868:Adaptor Proteins, Signal Transducing; C114545:CD2-associated protein; D003598:Cytoskeletal Proteins
references.citation: Neurobiol Aging. 2014 Apr;35(4):936.e5-12
references.pmid: 24176626
references.citation: Nat Genet. 2011 May;43(5):436-41
references.pmid: 21460841
references.citation: Nat Genet. 2011 May;43(5):429-35
references.pmid: 21460840
references.citation: Am J Epidemiol. 2012 Apr 15;175(8):739-49
references.pmid: 22427610
references.citation: PLoS One. 2012;7(12):e51571
references.pmid: 23251581
references.citation: Cold Spring Harb Protoc. 2012 Mar 01;2012(3):297-306
references.pmid: 22383645
references.citation: Alzheimers Dement. 2013 Sep;9(5):546-53
references.pmid: 23232270
references.citation: Mol Biol Rep. 2014 Mar;41(3):1299-310
references.pmid: 24407599
references.citation: J Alzheimers Dis. 2010;20(4):1107-18
references.pmid: 20413860
references.citation: PLoS One. 2013;8(4):e58618
references.pmid: 23565137
references.citation: Mol Neurobiol. 2014 Dec;50(3):757-64
references.pmid: 24643655
references.citation: J Neural Transm (Vienna). 2015 Mar;122(3):433-9
references.pmid: 24947876
references.citation: JAMA Neurol. 2013 Sep 1;70(9):1150-7
references.pmid: 23836404
references.citation: Neurobiol Aging. 2014 Apr;35(4):786-92
references.pmid: 24231519
references.citation: Neurosci Lett. 2013 Jun 7;544:47-51
references.pmid: 23570733
references.citation: Arch Neurol. 2011 Dec;68(12):1569-79
references.pmid: 22159054
references.citation: Intensive Care Med. 2006 Nov;32(11):1706-12
references.pmid: 16957907
references.citation: Mol Neurobiol. 2015;51(3):1017-23
references.pmid: 24878768
references.citation: Neurobiol Aging. 2013 Apr;34(4):1310.e9-10
references.pmid: 23040034
references.citation: Neuromolecular Med. 2014 Mar;16(1):52-60
references.pmid: 23892938
references.citation: Mol Neurodegener. 2011 Jul 28;6(1):54
references.pmid: 21798052
references.citation: Neuromolecular Med. 2013 Jun;15(2):384-8
references.pmid: 23572399
references.citation: J Neurochem. 2012 Jan;120(1):190-8
references.pmid: 22017384